It's not just public health advocates who are concerned about the FDA's recent direction on flavored products. Lawmakers on both sides of the aisle have objected, as the Wall Street Journal reported. This isn't a simple partisan divide — it's a broader debate about whether the FDA is striking the right balance between adult access and youth prevention.
Quote: "That only makes vaping more attractive to young people." — Sen. Susan Collins (R., Maine), speaking at a Senate hearing earlier this month about FDA's approval of blueberry and mango-flavored products (WSJ, Sept. 23, 2026)
Senator Collins is a Republican — which makes her criticism notable in an era where the issue often falls along predictable partisan lines. On the Democratic side, Senators Dick Durbin, Elizabeth Warren, and Richard Blumenthal have been vocal critics of the FDA's recent flavored product authorizations, sending letters demanding answers and calling for policy reversals.
Meanwhile, the legal challenges are mounting. Campaign for Tobacco-Free Kids and other public health groups have sued the Trump administration over the May 2026 enforcement guidance, arguing that the FDA violated federal law by making a major policy change without giving the public a chance to comment.
Why this matters for you: The Campaign for Tobacco-Free Kids lawsuit is built around the argument that the public was excluded from the policy process. That argument — if it gains traction in court — validates the importance of public comment. It also suggests that the FDA may need to open formal comment periods on these changes, creating a direct opportunity for adult vapers and consumers to make their voices heard.
If you're someone who uses vaping products as an alternative to smoking, or if you're concerned about youth access, this is not a moment to sit on the sidelines. The policy is being shaped right now — and the people making it need to hear from the people most affected by it.
